Top Markets
#1 XPIN Network XPIN Network +26.84%
#2 Geodnet Geodnet +23.03%
#3 Ore Ore +22.61%
#4 EXOD EXOD +22.08%
#5 Unit Zcash Unit Zcash +21.74%
#6 Verus Coin Verus Coin +20.46%
#7 The Black Bull The Black Bull +18.54%
#8 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +17.14%
#9 SSV Network SSV Network +16.67%
#10 Ethena Staked ENA Ethena Staked ENA +16.64%
Coin of the day
XPIN Network XPIN Network
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Orexo AB Orexo AB

Orexo AB

ORX
Pozycja w akcjach #24889
Orexo AB (publ), a specialty pharmaceutical company, develops and... Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, the United Kingdom, and internationally. Its products include Zubsolv tablets for the treatment of opioid use disorder; Abstral for the treatment of breakthrough pain in cancer patients; and Edluar for the treatment of insomnia. The company is developing OX124 for opioid overdose; OX125 for rescue medication and opioid overdose; OX640 to treat anaphylaxis with powder-based epinephrine; and OX-MPI for the treatment of endometriosis. Its digital therapies include deprexis for the treatment of depression; vorvida for alcohol management; and modia for opioid use disorder. The company has a collaboration agreement with Abera Bioscience AB to develop nasal powder vaccines based on the AmorphOX technology. Orexo AB (publ) was founded in 1994 and is headquartered in Uppsala, Sweden.
Cena akcji
$1.58
Kapitalizacja rynkowa
$55.48M
Zmiana (1 dzień)
0.86%
Zmiana (1 rok)
-28.33%
Kraj
SE
Handel Orexo AB (ORX)

Kategoria

Healthcare
Historia stopy dywidendy dla Orexo AB (ORX)
Stopa dywidendy (TTM) dla Orexo AB (symbol akcji: ORX) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla Orexo AB (ORX) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
1.58%
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
0.00%
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
0.00%
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
0.00%
US
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
2.09%
HK